Gregory Martini

Gregory Martini is recorded as CFO and Chief Accounting Officer at Kyverna Therapeutics, Inc. (KYTX) since May 18, 2026 and CFO at Ironwood Pharmaceuticals Inc (IRWD) since January 27, 2025. Kyverna Therapeutics, Inc. reported in an 8-K filed May 18, 2026 that Gregory Martini was appointed principal accounting officer, effective May 18, 2026. Kyverna Therapeutics, Inc. reported in an 8-K filed May 18, 2026 that Gregory Martini was appointed Chief Financial Officer, effective May 18, 2026. Ironwood Pharmaceuticals Inc reported in an 8-K filed May 13, 2026 that Gregory Martini resigned as Senior Vice President, Chief Financial Officer, effective May 15, 2026. Equibles holds 4 filed executive changes naming Gregory Martini; each is listed under recent activity with its source filing. Gregory Martini has spoken on 2 earnings calls across 1 company, most recently for Ironwood Pharmaceuticals Inc on May 7, 2026. Ironwood Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ironwood Pharmaceuticals Inc includes Tammi Gaskins (CEO and Board Member), Julie McHugh (Chairman and Board Member), Jason Rickard (CFO) and 7 others.